Found 825 results
Fields J, Dumaop W, Rockenstein E, Mante M, Spencer B, Grant I, Ellis RJ, Letendre S, Patrick C, Adame A, et al. Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. Journal of NeuroVirology [Internet]. 2013 ;19(1):89-101. Available from:
Fields J, Dumaop W, Adame A, Ellis RJ, Letendre S, Grant I, Masliah E. Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders. Journal of Neuroimmune Pharmacology [Internet]. 2013 ;8(5):1197-1209. Available from:
Tarassishin L, Bauman A, Suh H-S, Lee SC. Anti-viral and anti-inflammatory mechanisms of the innate immune transcription factor interferon regulatory factor 3: relevance to human CNS diseases. Journal of Neuroimmune Pharmacology. 2013 ;8(1):132-144.
Panos SE, Hinkin CH, Singer EJ, Thames AD, Patel SM, Sinsheimer JS, Del Re AC, Gelman B, Morgello S, Moore DJ, et al. Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity. Neurobehavioral HIV Medicine [Internet]. 2013 ;Volume 2013:5:11-22. Available from:
Cassol E, Misra V, Morgello S, Gabuzda D. Applications and Limitations of Inflammatory Biomarkers for Studies on Neurocognitive Impairment in HIV Infection. Journal of NeuroImmune Pharmacology [Internet]. 2013 ;8(5):1087-1097. Available from:
Shapshak P. Bioinformation editorial erratum. Bioinformation. 2013 ;9(3):168.
Colacurcio D, Yeager A, Kolson DL, Jordan-Sciutto KL, Akay C. Calpain-mediated degradation of MDMx/MDM4 contributes to HIV-induced neuronal damage. Molecular and Cellular Neurosciences [Internet]. 2013 ;57:54-62. Available from:
Pacifici M, Delbue S, Ferrante P, Jeansonne D, Kadri F, Nelson S, Velasco-Gonzalez C, Zabaleta J, Peruzzi F. Cerebrospinal Fluid miRNA Profile in HIV-Encephalitis. Journal of Cellular Physiology [Internet]. 2013 ;228(5):1070-1075. Available from:
Bahirwani R, Barin B, Olthoff K, Stock P, Murphy B, Rajender Reddy K. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the national institutes of health mu. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society [Internet]. 2013 ;19(6):619-26. Available from:
Marcotte TD, Deutsch R, Michael BDaniel, Franklin D, Cookson DRosario, Bharti AR, Grant I, Letendre S. A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals. J Neuroimmune Pharmacol. 2013 ;8(5):1123-35.
Hua X, Boyle CP, Harezlak J, Tate DF, Yiannoutsos CT, Cohen R, Schifitto G, Gongvatana A, Zhong J, Zhu T, et al. Disrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatment. Neuroimage Clin. 2013 ;3:132-42.
Langford D, Letendre S. Editorial commentary: Severe HIV-associated CD8+ T-cell encephalitis: is it the tip of the Iceberg?. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America [Internet]. 2013 ;57:109-11. Available from:
Yuferov V, Ho A, Morgello S, Yang Y, Ott J, Kreek MJ. Expression of ephrin receptors and ligands in postmortem brains of HIV-infected subjects with and without cognitive impairment. Journal of NeuroImmune Pharmacology [Internet]. 2013 ;8(1):333-344. Available from:
Spitsin S, Stevens K, Douglas SD. Expression of substance P, Neurokinin-1 receptor and immune markers in the brains of individuals with HIV-1 associated neuropathology. Journal of the Neurological Sciences [Internet]. 2013 ;334(1-2):18-23. Available from:
Lawhorn C, Yuferov V, Randesi M, Ho A, Morgello S, Kreek MJ, Levran O. Genetic diversity and linkage disequilibrium in the chemokine receptor CCR2-CCR5 region among individuals and populations. Cytokine [Internet]. 2013 ;64(2):571-576. Available from:
Joseph J, Achim C, Boivin MJ, Brew BJ, Clifford DB, Colosi DA, Ellis RJ, Heaton RK, Gallo-Diop A, Grant I, et al. Global NeuroAIDS roundtable. J Neurovirol. 2013 ;19(1):1-9.
Kumar A, Ownby RL, Fernandez JB, Valdes E, Kumar M. HIV -1 in the CNS in Post-cART era: Impact of Infection on Serotonin Status in Different Regions of Post Mortem Human Brain. In: International Society for NeuroVirology. International Society for NeuroVirology. New York, NY; 2013.
Gundavarapu S, Mishra NC, Singh SP, Langley RJ, Saeed AImran, Feghali-Bostwick CA, J McIntosh M, Hutt J, Hegde R, Buch S, et al. HIV gp120 induces mucus formation in human bronchial epithelial cells through CXCR4/α7-nicotinic acetylcholine receptors. PLoS One. 2013 ;8(10):e77160.
Orellanna JA, Saez JC, Bennett MV, Berman JW, Morgello S, Eugenin EA. HIV increases the release of dickkopf-1 protein from human astrocytes by a Cx43 hemichannel-dependent mechanism. Journal of Neurochemistry [Internet]. 2013 ;128(5):752-763. Available from:
Singer EJ, Valdes-Sueiras M, Commins D, Yong WH, Carlson M. HIV Stroke Risk: Evidence and Implications. Therapeutic Advances in Chronic Disease [Internet]. 2013 ;4(2):61-70. Available from:
Kumar A, Ownby RL, Fernandez JB, Singer EJ, Fonseca M, Kumar M. HIV-1 Infection in the CNS in Post-cART Era: Impact of Infection on Serotonergic Status in Different Regions of Post Mortem Brain. In: 12th International Symposium on NeuroVirology. 12th International Symposium on NeuroVirology. ; 2013.
Jacobs MM, Murray J, Byrd D, Hurd YL, Morgello S. HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1and DRD2 polymorphisms in substance-dependent and substance-independent populations. Journal of NeuroVirology [Internet]. 2013 ;19(5):495-504. Available from: